Skip to main content
ACoP 2024 Main banner
Final Program


Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Preconference

siRNA Therapies

First, Best, or Next in class? Applying forward and reverse translation approaches to accelerate siRNA projects from discovery to FIH.

Sunday, November 10, 2024
10:30 AM – 10:55 AM MST
Location: Sonoran Sky Ballroom 4

    Speaker(s)

  • Jeff Kearns, PhD (he/him/his)

    Director, Translational Modeling & Simulation
    Novartis
    Cambridge, Massachusetts, United States

    Disclosure(s): Novartis: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Sanofi: Employment (Ongoing); SK Life Science: Employment (Terminated, August 16, 2024)

Disclosure(s):
Jeff Kearns, PhD: Novartis: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Sanofi: Employment (Ongoing); SK Life Science: Employment (Terminated, August 16, 2024)